Lake Street Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,502
Closed -$799K 311
2023
Q3
$799K Buy
+6,502
New +$827K 0.14% 142
2022
Q2
Sell
-1,583
Closed -$206K 315
2022
Q1
$206K Sell
1,583
-5,500
-78% -$716K 0.04% 298
2021
Q4
$1.08M Buy
7,083
+1,187
+20% +$184K 0.19% 121
2021
Q3
$953K Sell
5,896
-13
-0.2% -$2.19K 0.23% 104
2021
Q2
$976K Sell
5,909
-384
-6% -$59.1K 0.25% 99
2021
Q1
$947K Buy
6,293
+1,897
+43% +$301K 0.26% 100
2020
Q4
$666K Buy
4,396
+1,269
+41% +$181K 0.19% 111
2020
Q3
$423K Sell
3,127
-165
-5% -$22.4K 0.14% 122
2020
Q2
$449K Buy
3,292
+566
+21% +$72.2K 0.17% 110
2020
Q1
$294K Buy
+2,726
New +$314K 0.13% 119

Other funds holding IBB

Lake Street Private Wealth's IBB Position: Q4 2023 in Review

Lake Street Private Wealth sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 6,502 shares — an estimated $799K sold.

Lake Street Private Wealth first reported a position in IBB in Q1 2020 and held it in 10 quarters. The position peaked at $1.08M in Q4 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Lake Street Private Wealth reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Lake Street Private Wealth sold 6,502 iShares Biotechnology ETF shares in Q4 2023, an estimated $799K.
  • Lake Street Private Wealth first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 10 quarters.
  • Lake Street Private Wealth's iShares Biotechnology ETF position peaked at $1.08M in Q4 2021.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Lake Street Private Wealth's 13F filing for Q4 2023, filed 10 Jan 2024.